3 European Ophthalmology Biotechs to Know
Ophthalmology is a booming niche, with investment flowing in, M&A up, and a burgeoning cast of biotechs – including the three European leaders profiled below – vying for a share…
Primex Pharmaceuticals is an innovative and fast-growing company spearheading a new pharmaceutical business model, in operation since early 2008. It is headquartered in Finland and Switzerland and has a global reach through regional marketing and distribution.
Primex supplies high-quality medicines to healthcare institutions and professionals around the world, from the EU to Asia, and from Latin America to the Middle East. Primex products are available in a total of 39 countries world-wide, while its distribution reaches a population of nearly one billion people.
There are unique medicines for hospital use and specialty practices, all are manufactured in the EU under the strictest quality controls. At present, Primex is specialized in anesthesia,cardiology, oncology and intensive care, and constantly expanding.
Primex is committed to building a profitable long-term business with its affiliates and partners. The Primex Alliance Network, connecting leading regional businesses and deep market knowledge, creates irreplaceable value and forms a strong base for the future of the whole network in all parts of the world. The leading pharmaceutical companies – in countries like Indonesia, Mexico and Saudi Arabia – form the base of Primex’s global success via regional excellence.
Contact
export@primexpharma.com
General Inquiries: +358 503 002 388
Business Development: +41 796 162 694
Export: +41 796 162 444
Primex Pharmaceuticals AG
Obmoos 4
CH-6300 Zug
Switzerland
Primex Pharmaceuticals Ltd
Eteläesplanadi 24 A
FI-00130 Helsinki
Finland
Ophthalmology is a booming niche, with investment flowing in, M&A up, and a burgeoning cast of biotechs – including the three European leaders profiled below – vying for a share…
Natural remedies are on the rise. The USD 80 billion global natural health products market is projected to nearly double by 2033, according to Market Growth Reports, as patients with…
Ophthalmology is one of the hottest niches in pharma right now. Investment is flowing in, M&A is up, and a broad cast of actors – from Big Pharma to legacy…
One in six infections worldwide is now resistant to first-line antibiotics, making antimicrobial resistance (AMR) a major global health threat. Despite an extremely challenging commercial landscape, a handful of bold…
Switzerland has become a global leader in cutting-edge cancer research, with close collaborations between research institutions, hospitals, and private industry fostering the next generation of globally impactful cancer innovation. …
As global trade tensions escalate, Switzerland’s export-driven pharmaceutical industry finds itself at a challenging moment. In May 2025, the United States imposed tariffs of up to 39 percent on Swiss…
In an uncertain world, Europe – with Switzerland at its heart – is reclaiming its role as an epicentre for testing, scaling, and integrating new medical technologies. While much…
Manufacturing – long sidelined as a relatively prosaic element of the global pharma supply chain – is back in the news. Investment in manufacturing facilities is skyrocketing as sponsors rush…
Switzerland stands among the world’s leading pharmaceutical manufacturing and export hubs; though that position now faces headwinds from recent US policy moves, as detailed elsewhere in this report. Yet making…
With the Trump administration imposing tariffs of up to 39 percent on Swiss goods (recently reduced to 15 percent), the pressure on Switzerland’s most influential industrial sector – pharmaceuticals –…
For a tiny Alpine nation nestled deep in the interior of continental Europe, Switzerland boasts a spectacularly vibrant biotech scene. This is because “the country manages to leverage its compact…
Helsinn has recently entered one of the most consequential transformations in its history. As it prepares for a new transition at the helm of the company, Executive Chairman Riccardo Braglia…
See our Cookie Privacy Policy Here
